MAI Capital Management Has $149,000 Holdings in Cel-Sci Corporation $CVM

MAI Capital Management cut its holdings in shares of Cel-Sci Corporation (NYSEAMERICAN:CVM) by 87.7% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 64,933 shares of the company’s stock after selling 461,547 shares during the period. MAI Capital Management owned approximately 0.94% of Cel-Sci worth $149,000 as of its most recent filing with the Securities and Exchange Commission.

Cel-Sci Trading Up 11.9%

NYSEAMERICAN CVM opened at $7.51 on Friday. Cel-Sci Corporation has a one year low of $1.98 and a one year high of $32.70. The company has a debt-to-equity ratio of 0.89, a current ratio of 0.47 and a quick ratio of 0.37. The firm has a market cap of $51.67 million, a P/E ratio of -0.77 and a beta of 0.52. The stock’s 50-day moving average is $8.27 and its 200-day moving average is $6.78.

About Cel-Sci

CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development of immune system therapy for the treatment of cancer and other diseases in the United States. The company's lead immunotherapy is Multikine, which has completed Phase 3 clinical trials for the potential treatment of certain head and neck cancers.